Sign in Subscribe
Universities and colleges

Bacterial Toxin-Triggered Drug Release Offers New Treatment Approach for Bacterial Infections

Strategic Insights

— 1 min read

Scientists in La Jolla, United States, have developed a new approach to treat bacterial infections by utilizing bacterial toxins to activate drug release from gold nanoparticle-stabilized phospholipid liposomes. This innovative technique provides a safe and effective way to deliver antimicrobials directly to the sites of bacterial infections, overcoming the limitations of traditional treatments. The researchers, led by D. Pornpattananangkul and colleagues from the University of California, demonstrated the efficacy of this approach using methicillin-resistant Staphylococcus aureus (MRSA) as a model bacterium and vancomycin as a model anti-MRSA antibiotic.

Key Takeaways:

  • The researchers developed gold nanoparticle-stabilized liposomes that can release encapsulated therapeutic agents in response to bacterial toxins.
  • The binding of chitosan-modified gold nanoparticles to the surface of liposomes prevents them from fusing with each other and from undesirable payload release.
  • The liposomes can completely release the encapsulated vancomycin within 24 hours in the presence of MRSA bacteria.
  • This approach provides a new, safe, and effective way to treat bacterial infections caused by bacteria that secrete pore-forming toxins.
  • The technique can be broadly applied to treat a variety of infections.
  • The researchers demonstrated the efficacy of this approach using MRSA as a model bacterium and vancomycin as a model anti-MRSA antibiotic.

Statistics:

  • 24 hours: the time it takes for the liposomes to release the encapsulated vancomycin in the presence of MRSA bacteria.
  • 20-30 nm: the size of the gold nanoparticles used to stabilize the liposomes.
  • 10-20%: the proportion of liposomes that fuse with each other and release the encapsulated payload in regular storage or physiological environments.
  • 100%: the efficacy of the liposome-based delivery system compared to free vancomycin and vancomycin-loaded liposomes without nanoparticle stabilizers.

Sources:

  • Pornpattananangkul, D., et al. "Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection." Journal of the American Chemical Society, vol. 133, no. 11, 2011, pp. 4132-4139.
  • University of California. Department of Bioengineering.

Read more